Consistent with the “depression-inducing” effects of pro-inflammatory cytokines, particularly TNF-α, several lines of evidence attested to the efficacy of selective TNF-α antagonists as a potential treatment for depression [96,97]. This evidence concerns the gene TNF and major depressive disorder.